Evidence map›Paper›PMID 34155538›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2021

Feasibility of late acquisition [68Ga]Ga-PSMA-11 PET/CT using a long axial field-of-view PET/CT scanner for the diagnosis of recurrent prostate cancer-first clinical experiences.

Ian Alberts, George Prenosil, Clemens Mingels, Karl Peter Bohn, Marco Viscione, Hasan Sari, Axel Rominger, Ali Afshar-Oromieh

Open access · hybridAbstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Total Body PET.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  4. Review
  5. Comparison of clinical performance between late and standard total-body [European journal of nuclear medicine and molecular imaging · 2025
    Article
  6. Review
  7. Total Body PET/CT: Future Aspects.Seminars in nuclear medicine · 2025
    Review
  8. Dose Reduction in Pediatric Oncology Patients with Delayed Total-Body [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  9. Article
  10. Comparison of Digital versus AnalogDiagnostics (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Article
  13. Inspired by novel radiopharmaceuticals: Rush hour of nuclear medicine.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2023
    Article
  14. Review
  15. Article
  16. Multiple angiolipomas visualized by dynamic and delayed "total-body" [European journal of nuclear medicine and molecular imaging · 2023
    Article
  17. Long axial field of view (LAFOV) PET-CT: implementation in static and dynamic oncological studies.European journal of nuclear medicine and molecular imaging · 2023
    Review
  18. Article
  19. Review
  20. Multi-timepoint imaging with PSMA-targeted [Annals of nuclear medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ian AlbertsDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland. ian.alberts@insel.ch.
George PrenosilDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland.
Clemens MingelsDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland.
Karl Peter BohnDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland.
Marco ViscioneDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland.
Hasan SariDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland.
Axel RomingerDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland.
Ali Afshar-OromiehDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland.
University of Bern · CHUniversity Hospital of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWhile acquisition of images in [

methodsIn this retrospective case series, we report our initial experiences with 10 patients who underwent standard imaging at 1 h p.i. following administration of 192 ± 36 MBq [

resultsSubjective image quality as rated on a 5-point Likert scale was only modestly lower for late acquisitions (4.2/5 at 4 h p.i.; 5/5 1 h p.i.), TBR was significantly improved (4 h: 3.41 vs 1 h: 1.93, p < 0.001) and SNR was improved with borderline significance (4 h: 33.02 vs 1 h: 24.80, p = 0.062) at later imaging. Images were obtained with total acquisition times comparable to routine examinations on standard axial FOV scanners.

conclusionLate acquisition in tandem with a LAFOV PET/CT resulted in improvements in TBR and SNR and was associated with only modest impairment in subjective visual imaging quality. These data show that later acquisition times for [

Indexed as

Positron Emission Tomography Computed TomographyProstatic NeoplasmsEdetic AcidFeasibility StudiesHumansMaleNeoplasm Recurrence, LocalRetrospective StudiesEdetic AcidDigital PETPET/CTPositron-emission tomographyTotal bodyUltra-long FOV PETWhole body

Identifiers

PMID34155538
PMCPMC8566391
OpenAlexW3177214580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.